Clinical Implications

ApoE genotyping as a progression-rate biomarker in phase II disease-modification trials for Alzheimer's disease

• D J Stone
• C Molony
• W Z Potter

Association of SUMO1 and UBC9 genotypes with tumor response in non-small-cell lung cancer treated with irinotecan-based chemotherapy

• Ji-Youn Han
• Geon Kook Lee
• Jin Soo Lee

Clinical implications of genetic polymorphisms on stomach cancer drug therapy

• G Toffoli
• E Cecchin

Pharmacogenetic of antirheumatic treatments: clinical implications

• G Ferraccioli
• B Tolusso
• M De Santis

Clinical implications of pharmacogenomics of statin treatment

• L M Mangravite
• C F Thorn
• R M Krauss

Pharmacogenomics and lung transplantation: clinical implications

• G J Burckart
• I V Hutchinson
• A Zeevi

Defining the clinical role of pharmacogenetics in antiepileptic drug therapy

• D J Dlugos
• R J Buono
• T N Ferraro

Availability of pharmacogenomics-based prescribing information in drug package inserts for currently approved drugs

• I Zineh
• T Gerhard
• A G Hartzema

Pharmacogenetic approaches to rheumatoid arthritis

• A Taniguchi
• N Kamatani

Genetic polymorphisms of the β-adrenergic system: association with essential hypertension and response to β-blockade

• F Filigheddu
• J E Reid
• N Glorioso

Clinical implications of pharmacogenomics for tardive dyskinesia

• D J Müller
• T Shinkai
• J L Kennedy

Pharmacogenetics in the treatment of breast cancer

• V Stearns
• N E Davidson
• D A Flockhart

Making sense of microarray data to classify cancer

• S Hanash
• C Creighton

Pharmacogenomic approaches to osteoporosis

• D-H Xiong
• J-R Long
• H-W Deng

Clinical implications of pharmacogenetics for glaucoma therapeutics

• N C McLaren
• S E Moroi

Pharmacogenetics of CYP2C9 and interindividual variability in anticoagulant response to warfarin

• H Takahashi
• H Echizen

Class struggle: expression profiling and categorizing cancer

• P A Covitz

Pharmacogenomic effects on therapy for acute lymphoblastic leukemia in children

• A M Wall
• J E Rubnitz

Attention-deficit/hyperactivity disorder: current aspects on pharmacogenetics

• L A Rohde
• T Roman
• M H Hutz

Elements of informed consent for pharmacogenetic research; perspective of the pharmacogenetics working group

• DC Anderson
• B Gomez-Mancilla
• CE Lister